Expand / Collapse search
Watch TV
☰

Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions.  Legal Statement.

This material may not be published, broadcast, rewritten, or redistributed. ©2026 FOX News Network, LLC. All rights reserved. FAQ - New Privacy Policy

corteva inc. - CTVA

CTVA

Close Chg Chg %
72.44 0.17 0.23%

Closed Market

72.61

+0.17 (0.23%)

Volume: 4.20M

Last Updated:

Feb 6, 2026, 3:59 PM EDT

Trade Now

Company Overview: corteva inc. - CTVA

CTVA Key Data

Open

$72.93

 Day Range

72.16 - 73.87

52 Week Range

53.40 - 77.41

 Market Cap

$50.76B

Shares Outstanding

675.73M

 Public Float

674.34M

Beta

0.75

 Rev. Per Employee

N/A

P/E Ratio

45.29

 EPS

$1.59

Yield

96.59%

 Dividend

$0.18

EX-DIVIDEND DATE

Mar 2, 2026

 SHORT INTEREST

N/A

AVERAGE VOLUME

4.18M

  

CTVA Performance

1 Week
 
 -0.27%
 
1 Month
 
 5.75%
 
3 Months
 
 13.17%
 
1 Year
 
 16.46%
 
5 Years
 
 65.38%
 

CTVA Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 27
Full Ratings ➔

About corteva inc. - CTVA

Corteva, Inc. engages in the provision of seed and crop protection solutions. It focuses on the agriculture industry and food supply. It operates through the Seed and Crop Protection segments. The Seed segment is involved in the development and supply of advanced germplasm and traits that produce yield for farms. The Crop Protection segment includes the global agricultural input industry with products for weeds, insects, other pests, and diseases protection, through nitrogen management and seed-applied technologies. The company was founded in 1802 and is headquartered in Indianapolis, IN.

CTVA At a Glance

Corteva, Inc.
9330 Zionsville Road
Indianapolis, Indiana 46268
Phone 1-833-267-8382 Revenue 17.40B
Industry Agricultural Commodities/Milling Net Income 1.09B
Sector Process Industries 2025 Sales Growth 2.916%
Fiscal Year-end 12 / 2026 Employees N/A
View SEC Filings

CTVA Valuation

P/E Current 45.294
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 41.894
Price to Sales Ratio 2.625
Price to Book Ratio 1.866
Price to Cash Flow Ratio 13.41
Enterprise Value to EBITDA 11.503
Enterprise Value to Sales 2.527
Total Debt to Enterprise Value 0.059

CTVA Efficiency

Revenue/Employee N/A
Income Per Employee N/A
Receivables Turnover 2.731
Total Asset Turnover 0.416

CTVA Liquidity

Current Ratio 1.43
Quick Ratio 0.962
Cash Ratio 0.374

CTVA Profitability

Gross Margin 43.589
Operating Margin 15.051
Pretax Margin 9.701
Net Margin 6.287
Return on Assets 2.852
Return on Equity 4.978
Return on Total Capital 4.464
Return on Invested Capital 4.596

CTVA Capital Structure

Total Debt to Total Equity 10.686
Total Debt to Total Capital 9.654
Total Debt to Total Assets 6.022
Long-Term Debt to Equity 6.983
Long-Term Debt to Total Capital 6.309
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Corteva Inc. - CTVA

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
17.45B 17.23B 16.91B 17.40B
Sales Growth
+11.50% -1.31% -1.85% +2.92%
Cost of Goods Sold (COGS) incl D&A
11.17B 10.59B 10.24B 9.82B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
1.22B 1.21B 1.23B 1.20B
Depreciation
521.00M 528.00M 542.00M 559.00M
Amortization of Intangibles
702.00M 683.00M 685.00M 644.00M
COGS Growth
+12.61% -5.20% -3.30% -4.17%
Gross Income
6.28B 6.63B 6.67B 7.58B
Gross Income Growth
+9.58% +5.60% +0.48% +13.80%
Gross Profit Margin
+35.98% +38.51% +39.42% +43.59%
2022 2023 2024 2025 5-year trend
SG&A Expense
4.39B 4.50B 4.59B 4.97B
Research & Development
1.22B 1.34B 1.40B 1.47B
Other SG&A
3.17B 3.16B 3.19B 3.49B
SGA Growth
-0.16% +2.53% +1.93% +8.26%
Other Operating Expense
- - 13.00M 11.00M
-
Unusual Expense
402.00M 382.00M 301.00M 362.00M
EBIT after Unusual Expense
1.49B 1.74B 1.77B 2.26B
Non Operating Income/Expense
15.00M (412.00M) (258.00M) (389.00M)
Non-Operating Interest Income
- 124.00M 283.00M 132.00M
Equity in Earnings of Affiliates
- 20.00M 10.00M 15.00M
Interest Expense
79.00M 233.00M 233.00M 180.00M
Interest Expense Growth
- +163.33% +194.94% -22.75%
Gross Interest Expense
79.00M 233.00M 233.00M 180.00M
Interest Capitalized
- - - -
-
Pretax Income
1.43B 1.09B 1.27B 1.69B
Pretax Income Growth
-39.22% -23.35% +16.65% +32.39%
Pretax Margin
+8.17% +6.35% +7.54% +9.70%
Income Tax
210.00M 152.00M 412.00M 484.00M
Income Tax - Current - Domestic
- 86.00M 183.00M 330.00M
Income Tax - Current - Foreign
- 403.00M 407.00M 447.00M
Income Tax - Deferred - Domestic
- (209.00M) (376.00M) (328.00M)
Income Tax - Deferred - Foreign
- (70.00M) (62.00M) (37.00M)
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- 20.00M 10.00M 15.00M
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
1.22B 941.00M 863.00M 1.20B
Minority Interest Expense
11.00M 12.00M 12.00M 11.00M
Net Income
1.21B 929.00M 851.00M 1.19B
Net Income Growth
-33.50% -22.90% -8.40% +40.19%
Net Margin Growth
+6.90% +5.39% +5.03% +6.86%
Extraordinaries & Discontinued Operations
(58.00M) (194.00M) 56.00M (99.00M)
Discontinued Operations
(58.00M) (194.00M) 56.00M (99.00M)
Net Income After Extraordinaries
1.15B 735.00M 907.00M 1.09B
Preferred Dividends
- - - -
-
Net Income Available to Common
1.15B 735.00M 907.00M 1.09B
EPS (Basic)
1.5913 1.0367 1.3075 1.6088
EPS (Basic) Growth
-33.43% -34.85% +26.12% +23.04%
Basic Shares Outstanding
720.80M 709.00M 693.70M 680.00M
EPS (Diluted)
1.5832 1.0324 1.3032 1.6
EPS (Diluted) Growth
-33.25% -34.79% +26.23% +22.77%
Diluted Shares Outstanding
724.50M 711.90M 696.00M 681.40M
EBITDA
3.12B 3.33B 3.29B 3.82B
EBITDA Growth
+20.78% +6.93% -1.11% +16.03%
EBITDA Margin
+17.85% +19.34% +19.48% +21.96%

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 80.905
Number of Ratings 27 Current Quarters Estimate 1.17
FY Report Date 03 / 2026 Current Year's Estimate 3.631
Last Quarter’s Earnings 0.22 Median PE on CY Estimate N/A
Year Ago Earnings 3.34 Next Fiscal Year Estimate 4.051
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 17 17 23 20
Mean Estimate 1.17 2.32 3.63 4.05
High Estimates 1.24 2.48 3.98 4.47
Low Estimate 1.09 2.18 3.20 3.76
Coefficient of Variance 3.79 3.46 4.31 4.07

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 15 16 16
OVERWEIGHT 5 5 5
HOLD 7 6 6
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Overweight Overweight Overweight

Insider Actions for Corteva Inc. - CTVA

Date Name Shares Transaction Value
Apr 9, 2025 Audrey Grimm SVP, Chief People Officer 20,677 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $55.79 per share 1,153,569.83
Apr 9, 2025 Robert King EVP, Crop Protection Business 62,220 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $55.79 per share 3,471,253.80
Feb 21, 2025 Sam Eathington See Remarks 63,038 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $64.46 per share 4,063,429.48
Feb 21, 2025 Audrey Grimm SVP, Chief People Officer 10,920 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 21, 2025 Brian Titus See Remarks 2,730 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 21, 2025 Brian Titus See Remarks 16,473 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 21, 2025 Brian Titus See Remarks 15,464 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $64.46 per share 996,809.44
Feb 21, 2025 David P. Johnson EVP, Chief Financial Officer 18,480 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 21, 2025 David P. Johnson EVP, Chief Financial Officer 64,573 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 21, 2025 Sam Eathington See Remarks 13,860 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 21, 2025 Sam Eathington See Remarks 68,158 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 21, 2025 Charles V. Magro Chief Executive Officer; Director 242,654 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $64.46 per share 15,641,476.84
Feb 21, 2025 Judd O'Connor EVP, Seed Business Unit 10,080 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 21, 2025 Judd O'Connor EVP, Seed Business Unit 36,977 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 21, 2025 Judd O'Connor EVP, Seed Business Unit 33,253 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $64.46 per share 2,143,488.38
Feb 21, 2025 Cornel B. Fuerer See Remarks 13,860 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 21, 2025 Cornel B. Fuerer See Remarks 140,687 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 21, 2025 Cornel B. Fuerer See Remarks 135,567 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $64.46 per share 8,738,648.82
Feb 21, 2025 Charles V. Magro Chief Executive Officer; Director 97,859 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 21, 2025 Charles V. Magro Chief Executive Officer; Director 231,896 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $63.82 per share 14,799,602.72

Corteva Inc. in the News